Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies 2016

Biofluid Biopsies 2016 Agenda




Friday, 27 May 2016


Agenda

08:00

Registration


Session I: CTC's as Liquid Biopsies

09:40

Chamindie PunyadeeraKeynote Presentation

Head and Neck Cancer Circulating Tumour Cells: Pathway to Personalised Medicine
Chamindie Punyadeera, Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia

This talk study will discuss about the clinical utility of CTCs in Head and Neck Cancer and its use as a liquid biopsy to guide patient treatment.

10:25

Circulating Tumour Cells and Cancer Prognosis
Ujjwala Warawdekar, Scientific Officer F, ACTREC, India

11:00

Coffee Break and Networking in Exhibition Area


Session II: Current Approaches in CTC's Detection

11:30

David SmithKeynote Presentation

Mate-pair Next Generation Sequencing for the Identification of Cancer-Specific Markers for Patients with Oropharyngeal Squamous Cell Carcinoma
David Smith, Professor, Mayo Clinic, United States of America

12:15

Pravin D PotdarKeynote Presentation

Can “Liquid Biopsies” Transform Cancer Diagnosis and Treatment in Near Future?
Pravin D Potdar, Head, Jaslok Hospital & Research Centre, India

This presentation will discuss the various protocols for enumeration and molecular profiling of CTCs in metastatic cancer patient to evaluate potential utility of liquid biopsies in the clinics in near future.

13:00

Microfluidics Lab-On-A-Chip Approaches For Circulating Tumor Cell Detection, Enumeration and Downstream Applications – Current Trends and Future Challenges
Shibichakravarthy Kannan, Founder & CEO, Theranosis Life Sciences Pvt Ltd, India

13:35

Lunch Break and Networking in Exhibition Area


Session III: Novel Screening Methodologies for Liquid Biopsies

14:35

A Universal Cancer Screening Test based on a Warburgian Extracellular Vesicle Biomarker
Winston Patrick Kuo, President, Predicine Holdings Ltd, United States of America

This presentation will discuss the novelty and impact of a membrane protein targeting tumour metabolism along with cancer-specific biomarkers in both circulating and specific sub-populations of extracellular vesicles in most solid tumours (colon, gastric, breast, lung, prostate, ovarian and melanoma) for purposes of screening, diagnostics and monitoring therapeutic treatments.

15:10

mRNA Detection in Extracellular Vesicles
Clark Chen, Co-Director, University of California-San Diego, United States of America

The talk will focus on the detection of glioblastoma specific mutations through the analysis of RNAs isolated from sera/cerebrospinal fluid EVs of glioblastoma patients. Implications pertaining to diagnostic development as well as pending challenges in clinical translation will also be discussed.

15:45

Circulating Nucleic Acids: Role in Hematological Malignancies
Suraj Shankar, Research Scholar, PES Institute of Technology, United Kingdom

16:20

Coffee and Networking Session

17:00

End of Conference